<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for SB 2889         </title>
<shortdesc>EPINEPHRINE ADMINISTRATION ACT</shortdesc>
<sponsor>
<sponsorhead1>Senate Sponsors</sponsorhead1><sponsors>Sen. Chapin Rose</sponsors>
<sponsorhead2>House Sponsors</sponsorhead2><altsponsors>(Rep. Peter Breen-David Harris-Marcus C. Evans, Jr.-Robert Martwick-Kelly M. Burke, Tony McCombie, Norine K. Hammond and Jonathan Carroll)</altsponsors>
</sponsor>
<lastaction>
<statusdate>8/10/2018</statusdate><chamber>Senate</chamber><action>Public Act . . . . . . . . . 100-0799</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>New Act</reference><aliasreference></aliasreference><reference>105 ILCS 5/22-30</reference><aliasreference></aliasreference><SynopsisText>Creates the Epinephrine Administration Act. Provides that a health care practitioner may prescribe epinephrine pre-filled syringes in the name of an authorized entity where allergens capable of causing anaphylaxis may be present. Provides that an authorized entity may acquire and stock a supply of undesignated epinephrine pre-filled syringes provided the undesignated epinephrine pre-filled syringes are stored in a specified location. Requires each employee, agent, or other individual of the authorized entity to complete a specified training program before using a pre-filled syringe to administer epinephrine. Provides that a trained employee, agent, or other individual of the authorized entity may either provide or administer an epinephrine pre-filled syringe to a person whom the employee, agent, or other individual believes in good faith is experiencing anaphylaxis. Provides that training under the Act shall be valid for 2 years. Requires the Department of Public Health to approve training programs, to list the approved programs on the Department's website, and to include links to training providers' websites on the Department's website. Contains provisions concerning costs, limitations, and rulemaking. Defines terms. Amends the School Code. In provisions concerning epinephrine administration, provides that epinephrine may be administered with a pre-filled syringe. Makes conforming changes.</SynopsisText><synopsistitle>Senate Committee Amendment No. 1</synopsistitle>
<reftype>Deletes reference to:</reftype><reference>New Act</reference><aliasreference></aliasreference><reftype>Adds reference to:</reftype><reference>410 ILCS 27/1</reference><aliasreference></aliasreference><reference>410 ILCS 27/5</reference><aliasreference></aliasreference><reference>410 ILCS 27/10</reference><aliasreference></aliasreference><reference>410 ILCS 27/15</reference><aliasreference></aliasreference><reference>410 ILCS 27/20</reference><aliasreference></aliasreference><reference>410 ILCS 620/3.21</reference><aliasreference>from Ch. 56 1/2, par. 503.21</aliasreference><SynopsisText>Replaces everything after the enacting clause. Reinserts the provisions of the introduced bill with the following changes: Amends the Epinephrine Auto-Injector Act and changes the short title to the Epinephrine Injector Act. Makes a corresponding change in the Illinois Food, Drug and Cosmetic Act. Defines "epinephrine injector" as including an auto-injector for the administration of epinephrine or a pre-filled syringe used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector. Deletes the definition for "epinephrine auto-injector". Changes references from "epinephrine auto-injector" to "epinephrine injector". Removes the provisions creating the Epinephrine Administration Act.</SynopsisText><synopsistitle>Senate Floor Amendment No. 2</synopsistitle>
<SynopsisText>Provides that the definition of "epinephrine injector" includes an auto-injector approved by the United States Food and Drug Administration for the administration of epinephrine and (rather than or) a pre-filled syringe approved by the United States Food and Drug Administration and used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector</SynopsisText></synopsis>
<actions>
<statusdate>2/14/2018</statusdate><chamber>Senate</chamber><action>Filed with Secretary by Sen. Chapin Rose</action>
<statusdate>2/14/2018</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>2/14/2018</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
<statusdate>2/21/2018</statusdate><chamber>Senate</chamber><action>Assigned to Public Health</action>
<statusdate>2/27/2018</statusdate><chamber>Senate</chamber><action>Postponed - Public Health</action>
<statusdate>3/2/2018</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Filed with Secretary by Sen. Chapin Rose</action>
<statusdate>3/2/2018</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Referred to Assignments</action>
<statusdate>3/13/2018</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Assignments Refers to Public Health</action>
<statusdate>3/13/2018</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Adopted</action>
<statusdate>3/14/2018</statusdate><chamber>Senate</chamber><action>Do Pass as Amended Public Health;  007-000-000</action>
<statusdate>3/14/2018</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 2nd Reading April 10, 2018</action>
<statusdate>4/10/2018</statusdate><chamber>Senate</chamber><action>Second Reading</action>
<statusdate>4/10/2018</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 3rd Reading April 11, 2018</action>
<statusdate>4/11/2018</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Filed with Secretary by Sen. Chapin Rose</action>
<statusdate>4/11/2018</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Referred to Assignments</action>
<statusdate>4/17/2018</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Assignments Refers to Public Health</action>
<statusdate>4/24/2018</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Recommend Do Adopt Public Health;  007-000-000</action>
<statusdate>4/25/2018</statusdate><chamber>Senate</chamber><action>Recalled to Second Reading</action>
<statusdate>4/25/2018</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Adopted; Rose</action>
<statusdate>4/25/2018</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 3rd Reading</action>
<statusdate>4/25/2018</statusdate><chamber>Senate</chamber><action>Third Reading - Passed; 057-000-000</action>
<statusdate>4/26/2018</statusdate><chamber>House</chamber><action>Arrived in House</action>
<statusdate>4/26/2018</statusdate><chamber>House</chamber><action>Chief House Sponsor Rep. Peter Breen</action>
<statusdate>4/26/2018</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>4/26/2018</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>5/7/2018</statusdate><chamber>House</chamber><action>Assigned to Human Services Committee</action>
<statusdate>5/16/2018</statusdate><chamber>House</chamber><action>Do Pass / Short Debate Human Services Committee;  012-000-000</action>
<statusdate>5/16/2018</statusdate><chamber>House</chamber><action>Added Alternate Chief Co-Sponsor Rep. David Harris</action>
<statusdate>5/16/2018</statusdate><chamber>House</chamber><action>Added Alternate Chief Co-Sponsor Rep. Marcus C. Evans, Jr.</action>
<statusdate>5/16/2018</statusdate><chamber>House</chamber><action>Added Alternate Chief Co-Sponsor Rep. Robert Martwick</action>
<statusdate>5/16/2018</statusdate><chamber>House</chamber><action>Added Alternate Chief Co-Sponsor Rep. Kelly M. Burke</action>
<statusdate>5/17/2018</statusdate><chamber>House</chamber><action>Placed on Calendar 2nd Reading - Short Debate</action>
<statusdate>5/18/2018</statusdate><chamber>House</chamber><action>Second Reading - Short Debate</action>
<statusdate>5/18/2018</statusdate><chamber>House</chamber><action>Placed on Calendar Order of 3rd Reading - Short Debate</action>
<statusdate>5/21/2018</statusdate><chamber>House</chamber><action>Third Reading - Short Debate - Passed 102-000-000</action>
<statusdate>5/21/2018</statusdate><chamber>House</chamber><action>Added Alternate Co-Sponsor Rep. Tony McCombie</action>
<statusdate>5/21/2018</statusdate><chamber>House</chamber><action>Added Alternate Co-Sponsor Rep. Jonathan Carroll</action>
<statusdate>5/21/2018</statusdate><chamber>House</chamber><action>Added Alternate Co-Sponsor Rep. Norine K. Hammond</action>
<statusdate>5/21/2018</statusdate><chamber>Senate</chamber><action>Passed Both Houses</action>
<statusdate>6/19/2018</statusdate><chamber>Senate</chamber><action>Sent to the Governor</action>
<statusdate>8/10/2018</statusdate><chamber>Senate</chamber><action>Governor Approved</action>
<statusdate>8/10/2018</statusdate><chamber>Senate</chamber><action>Effective Date January 1, 2019</action>
<statusdate>8/10/2018</statusdate><chamber>Senate</chamber><action>Public Act . . . . . . . . . 100-0799</action>
</actions>
</xml>

